1. Home
  2. Company search

Company search

KOBE Life Science Cluster Company List

Business Expansion
on Kobe's Port Island

370

companies

as of February 29, 2024

Companies are divided into categories by their major business field on Kobe Port Island. In the case they have other business fields, it is shown in the minor field.» List of KBIC companies(PDF)

≫ StartupsStartups Company List

Search by Company name or Keyword

Business sector search resultsProduction of Drugs and Quasi Drugs

110of Results 38

Re-search in Business sector
  1. 1
  2. 2
  3. 3
  4. 4
  5. >

Location search results

110of Results 38

Re-search in Location
  1. 1
  2. 2
  3. 3
  4. 4
  5. >

You can select the initial.

Initial search results

110of Results 38

Re-search in Initial
  1. 1
  2. 2
  3. 3
  4. 4
  5. >

Aeras Bio Inc.

Major field:Regenerative Medicine

Miner field:Production of Drugs and Quasi Drugs

Development of dental pulp stem cell technologies and marketing of oral care products

Overview

As a subsidiary of Air Water Group that has expanded its business from industrial gas to medical and dental related field. Aeras Bio was founded to promote oral care business and application of dental pulp stem cell technology.

Product / Service / PR

    In recent years oral health has received more attention for its link to body health. Above all, one of the key to prolong healthy lifespan is to keep your own tooth as long as possible. Aeras Bio is establishing a new therapy for treating severe cavities and pulpitis. Dental pulp regenerative therapy revives dental pulp by taking dental pulp stem cell from unwanted tooth in orthodontic treatment or wisdom tooth, then transplant the stem cell to tooth after pulp extraction (root canal), subsequently regenerate the dental pulp. In addition to clinical research in pulp regeneration and enamel regeneration, Aeras Bio is concurrently working on cell extraction, cell culture, preservation and transportation of dental pulp stem cell from unwanted tooth.
Address: 1-3-1, Minatojima-minamimachi, Chuo-ku, Kobe, 650-0047 JAPAN  (Contact Person Morita Yuko)
TEL: +81-78-303-0031 FAX: +81-78-303-0031
Web site: https://aerasbio.co.jp/ E-mail: info-aerasbio-h@awi.co.jp

AlliedCel Corporation

Major field:Regenerative Medicine

Miner field:Drug Discovery

Miner field:Production of Drugs and Quasi Drugs

AMTEC CO.,LTD.

Major field:Chemical Synthesis

Miner field:Production of Drugs and Quasi Drugs

Miner field:Medical Equipment

Atomis Inc.

Major field:Material and Chemical Products

Miner field:Packaging

Miner field:Production of Drugs and Quasi Drugs

Creation of new applications based on next-generation porous materials PCP/MOF

Overview

Atomis is engaged in two businesses using PCP/MOF, a porous coordination polymer discovered at Kyoto University for the first time in the world, as a fundamental technology.
(1) Materials Business: Design, evaluation, manufacturing and sales of PCP/MOF
(2) Impact Business: Development of distributed CO2 separation and conversion module (DCCU) and innovative high-pressure gas container CubiTan® (DGRU)

Product / Service / PR

    (1)In silico molecular design using original database of PCP/MOF
    (2)Synthesis and evaluation of various porous materials containing PCP/MOF
    (3)Mass production of PCP/MOF
    (4)Provision of high-pressure gas infrastructure using innovative high-pressure gas container CubiTan®
Address: 7-4-9 Minatojimaminamimachi Chuo-ku, Kobe-shi, Hyogo 650-0047, Japan  (Contact Person Kenji Sumida)
Web site: https://www.atomis.co.jp/en/ E-mail: info@atomis.co.jp

Bacchus Bio innovation Co., Ltd.

Major field:Material and Chemical Products

Miner field:Contract Research

Miner field:Production of Drugs and Quasi Drugs

Integrated biofoundry

Overview

Utilizing biotechnology (genome editing technology, DNA synthesis technology, etc.) and digital technology (IT and AI), we can design microorganisms to produce new substances (Design), create the designed microorganisms (Build), select excellent microorganisms from among the created microorganisms (Test), and analyze the measured data from the constructed microorganisms (Learn). The DBTL flow is rotated at a high speed to enhance functions and add new functions to microorganisms, including the integrated analysis of measured data (Learn). We can efficiently produce various substances such as pharmaceutical raw materials, fuels, plastics, food additives, and cosmetic raw materials.

Product / Service / PR

    In health and medical industry, even if a drug candidate with excellent efficacy and effectiveness is discovered, product development is often suspended because it cannot be mass-produced or commercialized using conventional chemical synthesis and cultivation methods. Our technology enables the efficient production of pharmaceutical raw materials or intermediates of microbial origin, and contributes to the reduction of drug prices of existing products.
Address: Head office location
1-1 Rokkodai-cho, Nada-ku, Kobe, Hyogo 657-0013, Japan 
Bio-Foundry
6-3-7 Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan Creative Lab Kobe 505 
(Contact Person Shogo Harumoto)
TEL: +81-78-599-5717 FAX: +81-78-599-5718
Web site: https://www.b2i.co.jp/ E-mail: info@b2i.co.jp

Bee Brand Medico Dental Co., Ltd.

Major field:Production of Drugs and Quasi Drugs

Miner field:Medical Equipment

Miner field:Cosmetic

R&D of dental medication, quasi drugs, and dental equipments

Bonanza Co.,Ltd.

Major field:Cosmetic

Miner field:Production of Drugs and Quasi Drugs

R&D, production and sales, OEM of cosmetics and dietary supplements

Cyto-Facto Inc.

Major field:Regenerative Medicine

Miner field:Contract Research

Miner field:Production of Drugs and Quasi Drugs

Specialized in manufacturing cell and gene products as CDMO

Overview

Services we provide in the field of cell & gene therapy
1. Contracted manufacturing of commercial products (CMO)
2. Process development and manufacturing of clinical products (CDMO)
3. Quality control testing of CGT products for commercial, clinical and research use
4. Development, sales, and service business of manufacturing management systems
5. Consultation for regulatory issues

Product / Service / PR

    Cyto-Facto (its predecessor, the RDC of the FBRI) is the first Asian company to manufacture commercial CAR-T products in compliance with PIC/S GMP. Cyto-Facto has accumulated experience in manufacturing technology know-how and has launched several cell & gene manufacturing pipelines, including CAR-T, iPSC-based cells and mesenchymal stem cells (MSCs) of various developmental stages.
Address: TRI 3F 1-5-4 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047 Japan  (Contact Person Takeshi Itoh)
TEL: +81-78-306-0681
Web site: https://www.cytofacto.com/eng/ E-mail: info@cytofacto.com

DAIKIN APPLIED SYSTEMS CO.,LTD

Major field:Production Equipment

Miner field:Regenerative Medicine

Miner field:Production of Drugs and Quasi Drugs

Total engineering from construction and maintenance of factories and CPC in the field of drugs and cell culturing

Enomoto Pharmaceutical Co.,Ltd

Major field:Production of Drugs and Quasi Drugs

Wholesale of generic drugs.

Overview

Wholesale of medicinal drugs

Product / Service / PR

    We are selling Japanese government-approved medical drugs to hospitals and pharmacies.
Address: 6-5-5 Minatojima-Minami, Chuo, Kobe, Hyogo 564-0044, JAPAN  (Contact Person Masahiro Enomoto, M.D., Ph.D.)
TEL: +81-6-6385-1401 FAX: +81-6-6330-0465
Web site: http://www.enomoto-yakuhin.co.jp/index.html E-mail: masahiro@enomoto-yakuhin.co.jp